Hyundai Pharmaceutical현대약품
004310 · KOSPI · ₩004310 · 현대약품
₩6,880▲ ₩30 (0.44%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Quarterly report (Aug 2026)분기보고서 (2026.08)Oct 15, 2026Open on DART
Predicted impact: Low· Actual: −7.3% vs sector, volume 0.4× normal (5 trading days)
Routine quarterly report with no surprise or unusual disclosed items.
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Jul 15, 2026Open on DART
- Half-year report (May 2026)반기보고서 (2026.05)Jul 15, 2026Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시Jun 1, 2026Open on DART
- Quarterly report (Feb 2026)분기보고서 (2026.02)Apr 14, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Mar 26, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Mar 4, 2026Open on DART
- Acquisition of shares in another company타법인주식및출자증권취득결정Feb 27, 2026Open on DART
- Major Matters Report (Decision on Acquisition of Shares and Equity Securities of Other Corporation)주요사항보고서(타법인주식및출자증권양수결정)Feb 27, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Feb 27, 2026Open on DART
- Amended: Treasury share sale decision[기재정정]주요사항보고서(자기주식처분결정)Feb 27, 2026Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Feb 26, 2026Open on DART
- Annual general meeting results정기주주총회결과Feb 24, 2026Open on DART
- Audit report submitted감사보고서제출Feb 13, 2026Open on DART
- Annual report (Nov 2025)사업보고서 (2025.11)Feb 13, 2026Open on DART
- Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Feb 9, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 9, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 9, 2026Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Feb 9, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Feb 9, 2026Open on DART
- Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Jan 5, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Nov 14, 2025Open on DART
- Quarterly report (Aug 2025)분기보고서 (2025.08)Oct 15, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Sep 29, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Jul 30, 2025Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Jul 14, 2025Open on DART
- Half-year report (May 2025)반기보고서 (2025.05)Jul 14, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Apr 29, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Apr 28, 2025Open on DART
- Quarterly report (Feb 2025)분기보고서 (2025.02)Apr 14, 2025Open on DART
- Annual general meeting results정기주주총회결과Feb 27, 2025Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Feb 27, 2025Open on DART
- Audit report submitted감사보고서제출Feb 19, 2025Open on DART
- Added attachment: Annual report (Nov 2024)[첨부추가]사업보고서 (2024.11)Feb 19, 2025Open on DART
- Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Feb 12, 2025Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 12, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Feb 12, 2025Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Feb 12, 2025Open on DART
- Notice of shareholders' meeting주주총회소집공고Feb 12, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Feb 11, 2025Open on DART
- Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Jan 6, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Dec 31, 2024Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Dec 16, 2024Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Nov 15, 2024Open on DART
- Quarterly report (Aug 2024)분기보고서 (2024.08)Oct 15, 2024Open on DART
- Designation as Company for Unfaithful Disclosure불성실공시법인지정Sep 20, 2024Open on DART
- Notice of Planned Designation as Unfaithful Disclosure Company불성실공시법인지정예고Aug 23, 2024Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Aug 20, 2024Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Jul 12, 2024Open on DART
- Half-year report (May 2024)반기보고서 (2024.05)Jul 12, 2024Open on DART
Titles in Korean until English translations are added.
Also known as: Hyundai Pharmaceutical / 현대약품 / 004310 / KRX:004310
Source: KRX statistical information